Skip to main content
. 2017 Nov 27;96(47):e8902. doi: 10.1097/MD.0000000000008902

Figure 3.

Figure 3

Dose–response curves of sevoflurane for supraglottic airway device insertion in obese patients. The curves plotted from probit regression analysis of individual end-tidal concentration of sevoflurane and the reactions to supraglottic airway device insertion in obese patients. The end-tidal concentrations at which there were 50% and 95% probabilities of successful supraglottic airway device insertion were 2.09% (95% CI 1.48–2.68) and 3.31% (95% CI 2.70–8.12), respectively.